Literature DB >> 17698566

The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity.

Daniel N Wolfe1, Elizabeth M Goebel, Ottar N Bjornstad, Olivier Restif, Eric T Harvill.   

Abstract

Bordetella pertussis and Bordetella parapertussis are closely related endemic human pathogens which cause whooping cough, a disease that is reemerging in human populations. Despite how closely related these pathogens are, their coexistence and the limited efficacy of B. pertussis vaccines against B. parapertussis suggest a lack of cross-protective immunity between the two. We sought to address the ability of infection-induced immunity against one of these pathogens to protect against subsequent infection by the other using a mouse model of infection. Immunity induced by B. parapertussis infection protected against subsequent infections by either species. However, immunity induced by B. pertussis infection prevented subsequent B. pertussis infections but did not protect against B. parapertussis infections. The O antigen of B. parapertussis inhibited binding of antibodies to the bacterial surface and was required for B. parapertussis to colonize mice convalescent from B. pertussis infection. Thus, the O antigen of B. parapertussis confers asymmetrical cross-immunity between the causative agents of whooping cough. We propose that these findings warrant investigation of the relative role of B. parapertussis in the resurgence of whooping cough.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17698566      PMCID: PMC2044517          DOI: 10.1128/IAI.00763-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  62 in total

1.  Ecological interference between fatal diseases.

Authors:  P Rohani; C J Green; N B Mantilla-Beniers; B T Grenfell
Journal:  Nature       Date:  2003-04-24       Impact factor: 49.962

2.  Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica.

Authors:  Julian Parkhill; Mohammed Sebaihia; Andrew Preston; Lee D Murphy; Nicholas Thomson; David E Harris; Matthew T G Holden; Carol M Churcher; Stephen D Bentley; Karen L Mungall; Ana M Cerdeño-Tárraga; Louise Temple; Keith James; Barbara Harris; Michael A Quail; Mark Achtman; Rebecca Atkin; Steven Baker; David Basham; Nathalie Bason; Inna Cherevach; Tracey Chillingworth; Matthew Collins; Anne Cronin; Paul Davis; Jonathan Doggett; Theresa Feltwell; Arlette Goble; Nancy Hamlin; Heidi Hauser; Simon Holroyd; Kay Jagels; Sampsa Leather; Sharon Moule; Halina Norberczak; Susan O'Neil; Doug Ormond; Claire Price; Ester Rabbinowitsch; Simon Rutter; Mandy Sanders; David Saunders; Katherine Seeger; Sarah Sharp; Mark Simmonds; Jason Skelton; Robert Squares; Steven Squares; Kim Stevens; Louise Unwin; Sally Whitehead; Bart G Barrell; Duncan J Maskell
Journal:  Nat Genet       Date:  2003-08-10       Impact factor: 38.330

3.  Epidemiology and characterization of Bordetella parapertussis strains isolated between 1995 and 2002 in and around Warsaw, Poland.

Authors:  I Letowska; W Hryniewicz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-05-27       Impact factor: 3.267

Review 4.  Duration of immunity against pertussis after natural infection or vaccination.

Authors:  Aaron M Wendelboe; Annelies Van Rie; Stefania Salmaso; Janet A Englund
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

5.  The changing age and seasonal profile of pertussis in Canada.

Authors:  Danuta M Skowronski; Gaston De Serres; Diane MacDonald; Wrency Wu; Carol Shaw; Jane Macnabb; Sylvie Champagne; David M Patrick; Scott A Halperin
Journal:  J Infect Dis       Date:  2002-04-22       Impact factor: 5.226

6.  Molecular evolution and host adaptation of Bordetella spp.: phylogenetic analysis using multilocus enzyme electrophoresis and typing with three insertion sequences.

Authors:  A van der Zee; F Mooi; J Van Embden; J Musser
Journal:  J Bacteriol       Date:  1997-11       Impact factor: 3.490

7.  Parapertussis and pertussis: differences and similarities in incidence, clinical course, and antibody responses.

Authors:  E Bergfors; B Trollfors; J Taranger; T Lagergård; V Sundh; G Zackrisson
Journal:  Int J Infect Dis       Date:  1999       Impact factor: 3.623

8.  Role of Bordetella O antigen in respiratory tract infection.

Authors:  Valorie C Burns; Elizabeth J Pishko; Andrew Preston; Duncan J Maskell; Eric T Harvill
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

9.  Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing.

Authors:  Ulrich Heininger; Peggy A Cotter; Howard W Fescemyer; Guillermo Martinez de Tejada; Ming H Yuk; Jeff F Miller; Eric T Harvill
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

10.  Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolates.

Authors:  P Mastrantonio; P Stefanelli; M Giuliano; Y Herrera Rojas; M Ciofi degli Atti; A Anemona; A E Tozzi
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

View more
  24 in total

1.  Imperfect vaccine-induced immunity and whooping cough transmission to infants.

Authors:  Jennie Lavine; Hélène Broutin; Eric T Harvill; Ottar N Bjørnstad
Journal:  Vaccine       Date:  2010-10-27       Impact factor: 3.641

2.  Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis.

Authors:  Xuqing Zhang; Sara E Hester; Mary J Kennett; Alexia T Karanikas; Liron Bendor; David E Place; Eric T Harvill
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  Evidence for horizontal gene transfer of two antigenically distinct O antigens in Bordetella bronchiseptica.

Authors:  Anne M Buboltz; Tracy L Nicholson; Alexia T Karanikas; Andrew Preston; Eric T Harvill
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

4.  Bordetella parapertussis survives inside human macrophages in lipid raft-enriched phagosomes.

Authors:  Juan Gorgojo; Eric T Harvill; Maria Eugenia Rodríguez
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

Review 5.  Contribution of pertussis toxin to the pathogenesis of pertussis disease.

Authors:  Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2015-09-21       Impact factor: 3.166

6.  O antigen protects Bordetella parapertussis from complement.

Authors:  Elizabeth M Goebel; Daniel N Wolfe; Kelly Elder; Scott Stibitz; Eric T Harvill
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

7.  O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies.

Authors:  Xuqing Zhang; Maria Eugenia Rodríguez; Eric T Harvill
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

8.  T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis.

Authors:  Pascal Feunou Feunou; Julie Bertout; Camille Locht
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240

9.  A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice.

Authors:  Ciaran M Skerry; Joseph P Cassidy; Karen English; Pascal Feunou-Feunou; Camille Locht; Bernard P Mahon
Journal:  Clin Vaccine Immunol       Date:  2009-07-22

10.  Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection.

Authors:  Elizabeth M Goebel; Xuqing Zhang; Eric T Harvill
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.